CompanyGraph
At a glance
- Depends onMidstream position: 5 outgoing, 4 incoming connections
- ScaleLevered free cash flow is $45.74M, above the global median of $18.73M
- FinancialsAltman Z-Score 2.72: safe zone
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
1.32%
Annual Rate
CNY 0.05Paid annual
Payout Ratio
175.0%High
Payback Period
77.8 yr
Last Ex-Dividend
May 28, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
4.50BCNY671.06M · vs all stocks (USD)
Trailing P/E
94.50xRevenue (TTM)
1.66BCNY247.27M · vs all stocks (USD)
Profit Margin
3.60%Beta
0.2450xvs all stocks
52-Week Change
-14.67%vs all stocks
Market Capitalization
4.50BCNY671.06M · vs all stocks (USD)
Enterprise Value
4.19BCNY625.79M · vs all stocks (USD)
Trailing P/E
94.50xForward P/E
9.95xPrice to Sales (TTM)
2.71xPrice to Book (MRQ)
1.02xEnterprise to Revenue
2.53xEnterprise to EBITDA
14.61xGross Margin
38.66%Profit Margin
3.60%Operating Margin
11.89%Return on Assets (TTM)
0.93%Return on Equity (TTM)
1.34%Revenue (TTM)
1.66BCNY247.27M · vs all stocks (USD)
Revenue per Share (TTM)
1.26CNYUpdated Sep 20, 2026Quarterly Revenue Growth
-4.60%Gross Profit (TTM)
603.21MCNY90.01M · vs all stocks (USD)
EBITDA (TTM)
244.24MCNY36.45M · vs all stocks (USD)
Net Income (TTM)
59.65MCNY8.90M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
-7.30%Operating Cash Flow (TTM)
435.15MCNY64.93M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
306.51MCNY45.74M · vs all stocks (USD)
Trailing Annual Dividend Rate
0.0500CNYUpdated Sep 20, 2026Trailing Annual Dividend Yield
1.32%vs all stocks
Payout Ratio
175.00%Minority Interest (Equity)
1.74MCNYFY2025 · Dec 31, 2025Revenue
1.74BCNYFY2025 · Dec 31, 2025Cost of Goods Sold
1.10BCNYFY2025 · Dec 31, 2025Gross Profit
642.58MCNYFY2025 · Dec 31, 2025Operating Income
96.38MCNY14.38M · vs all stocks (USD)
Pre-tax Income
83.24MCNYFY2025 · Dec 31, 2025Income Tax Expense
6.76MCNYFY2025 · Dec 31, 2025Net Income
76.49MCNYFY2025 · Dec 31, 2025EBIT
105.40MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
468.43MCNYFY2025 · Dec 31, 2025Research & Development
134.66MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
220.13MCNYFY2025 · Dec 31, 2025Other Operating Expenses
40.38MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
29.90MCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
22.15MCNYFY2025 · Dec 31, 2025EPS (Basic)
0.0600CNYFY2025 · Dec 31, 2025EPS (Diluted)
0.0600CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
1.28BSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
1.28BSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
76.49MCNYFY2025 · Dec 31, 2025Minority Interests (P&L)
511.47KCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
370.11MCNYFY2025 · Dec 31, 2025Free Cash Flow
267.59MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
828.45MCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
76.49MCNYFY2025 · Dec 31, 2025Other Non-cash Items
22.35MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
77.95MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
193.33MCNYFY2025 · Dec 31, 2025Capital Expenditures
-102.52MCNYFY2025 · Dec 31, 2025Purchase of Investments
-260.00MCNYFY2025 · Dec 31, 2025Sale of Investments
163.91MCNYFY2025 · Dec 31, 2025Other Investing Activity
-23.94MCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
-222.56MCNYFY2025 · Dec 31, 2025Long-term Debt Issuance
1.05BCNYFY2025 · Dec 31, 2025Long-term Debt Payments
-971.15MCNYFY2025 · Dec 31, 2025Common Dividends Paid
-104.99MCNYFY2025 · Dec 31, 2025Other Financing Charges
14.39MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
-9.96MCNYFY2025 · Dec 31, 2025Shares Outstanding
1.19BSharesUpdated Sep 20, 2026Float Shares
840.98MSharesUpdated Sep 20, 2026% Held by Insiders
31.58%vs all stocks
% Held by Institutions
0.42%vs all stocks
Total Cash (MRQ)
899.88MCNY134.28M · vs all stocks (USD)
Total Cash per Share (MRQ)
0.7560CNYUpdated Sep 20, 2026Total Debt (MRQ)
595.02MCNY88.79M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.1352xCurrent Ratio (MRQ)
2.23xBook Value per Share (MRQ)
3.70CNYUpdated Sep 20, 2026Total Assets
5.76BCNY860.02M · vs all stocks (USD)
Total Current Assets
1.95BCNYFY2025 · Dec 31, 2025Total Liabilities
1.40BCNYFY2025 · Dec 31, 2025Total Non-current Assets
3.82BCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
558.36MCNYFY2025 · Dec 31, 2025Total Current Liabilities
839.57MCNYFY2025 · Dec 31, 2025Cash
876.76MCNYFY2025 · Dec 31, 2025Cash Equivalents
9.86MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
886.62MCNYFY2025 · Dec 31, 2025Other Short-term Investments
150.05MCNYFY2025 · Dec 31, 2025Accounts Receivable
151.23MCNYFY2025 · Dec 31, 2025Inventory
643.05MCNYFY2025 · Dec 31, 2025Accounts Payable
274.86MCNYFY2025 · Dec 31, 2025Short-term Debt
394.26MCNYFY2025 · Dec 31, 2025Other Current Liabilities
27.22MCNYFY2025 · Dec 31, 2025Long-term Debt
406.16MCNYFY2025 · Dec 31, 2025Other Non-current Liabilities
10.00KCNYFY2025 · Dec 31, 2025Common Stock (Book)
1.19BCNYFY2025 · Dec 31, 2025Retained Earnings
833.44MCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
4.37BCNY651.42M · vs all stocks (USD)
52-Week Low
3.24CNYUpdated Sep 20, 202652-Week High
5.00CNYUpdated Sep 20, 202652-Week Change
-14.67%vs all stocks
Beta
0.2450xvs all stocks
50-Day MA
3.85CNYUpdated Sep 20, 2026200-Day MA
4.09CNYUpdated Sep 20, 2026Avg 10-Day Volume
11.20MSharesUpdated Sep 20, 2026Avg 30-Day Volume
20.58MSharesUpdated Sep 20, 2026Diluted EPS (TTM)
0.0400CNYUpdated Sep 20, 2026Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
Altman Z-Score 2.72: safe zoneNotable
Altman Z-Score: 2.72
Supply Chain
Midstream position: 5 outgoing, 4 incoming connectionsNotable
Outgoing: 5.00Incoming: 4.00
Scale
Levered free cash flow is $45.74M, above the global median of $18.73MNotable
Levered free cash flow (USD): 45,737,295.661Global Median: 18,729,043.027
Companies that share the same coordination system — how they create, deliver, or capture value.
Zevra Therapeutics, Inc.
Tier 1ProductionApproval-Gated PipelineRule
Climb Biotherapeutics, Inc.
Tier 1ProductionApproval-Gated PipelineRuleRisk
Senores Pharmaceuticals Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Hangzhou AGS Medtech Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Sinotherapeutics Inc.
Tier 1ProductionApproval-Gated PipelineRule
Shanghai Kinetic Medical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Hunan Hansen Pharmaceutical Co. Ltd.
Tier 1ProductionApproval-Gated PipelineRule
MiMedx Group, Inc.
Tier 1ProductionApproval-Gated PipelineRule
Nuvectis Pharma Inc.
Tier 1ProductionApproval-Gated PipelineRule
Henan Taloph Pharmaceutical Co. Ltd.
Tier 1ProductionApproval-Gated PipelineRule